Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia

Status Completed

Clinical Trial Summary

The objectives of this study are to assess the effects of 4 g/d P-OM3, compared with placebo, on LDL-C and other aspects of the fasting lipid profile in subjects with primary hypercholesterolemia.

Clinical Trial Description

This trial will utilize a randomized, double-blind, two-period crossover design. At Visit 2 (Week 0), subjects meeting all entry criteria will be randomized to one of two treatment sequences: placebo or P-OM3 for the first 6 week phase followed by the study product they did not receive during the first phase (P-OM3 or placebo) for the second 6 weeks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00746811
Study type	Interventional
Source	Provident Clinical Research
Contact
Status	Completed
Phase	Phase 4
Start date	January 2010
Completion date	October 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05559606` - An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe
Completed	`NCT03571087` - Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia	Phase 3
Completed	`NCT00776321` - Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia	Phase 2
Recruiting	`NCT05399992` - Study Evaluating Effectiveness and Adherence of Inclisiran Plus Standard of Care (SoC) Lipid-lowering Therapy Compared to SoC in ASCVD
Withdrawn	`NCT05798390` - Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed Dyslipidemia
Completed	`NCT06448962` - Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022	Phase 3
Completed	`NCT00724477` - Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED)
Completed	`NCT00249249` - Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels	Phase 3
Recruiting	`NCT05657574` - A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia	Phase 3
Completed	`NCT03516955` - Efficacy and Safety of a Generic Rosuvastatin in a Real-world Setting
Completed	`NCT02941848` - Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers	Phase 1
Completed	`NCT01012219` - A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)	Phase 1
Completed	`NCT05131997` - A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A	Phase 3
Terminated	`NCT03433755` - Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia	Phase 3
Completed	`NCT00867165` - Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)	Phase 3
Not yet recruiting	`NCT06386419` - A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia	Phase 4
Active, not recruiting	`NCT03952169` - Effect of Probiotics on Lipid Management	N/A
Terminated	`NCT01335997` - Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)	Phase 3
Completed	`NCT02087917` - A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia	Phase 2
Completed	`NCT00704535` - Evaluation of the Safety, Tolerability and Efficacy of Ezetimibe on a Select Population of Filipinos With Hypercholesterolemia (Study P04748)(COMPLETED)